scholarly journals A phase I trial of the MEK inhibitor selumetinib (AZD6244) in pediatric patients with recurrent or refractory low-grade glioma: a Pediatric Brain Tumor Consortium (PBTC) study

2017 ◽  
Vol 19 (8) ◽  
pp. 1135-1144 ◽  
Author(s):  
Anuradha Banerjee ◽  
Regina I. Jakacki ◽  
Arzu Onar-Thomas ◽  
Shengjie Wu ◽  
Theodore Nicolaides ◽  
...  
2015 ◽  
Vol 31 (8) ◽  
pp. 1283-1289 ◽  
Author(s):  
Lindsey M. Hoffman ◽  
Maryam Fouladi ◽  
James Olson ◽  
Vinay M. Daryani ◽  
Clinton F. Stewart ◽  
...  

2007 ◽  
Vol 9 (2) ◽  
pp. 145-160 ◽  
Author(s):  
Ian F. Pollack ◽  
Regina I. Jakacki ◽  
Susan M. Blaney ◽  
Michael L. Hancock ◽  
Mark W. Kieran ◽  
...  

2010 ◽  
Vol 28 (15_suppl) ◽  
pp. 9502-9502 ◽  
Author(s):  
M. Fouladi ◽  
J. Olson ◽  
C. F. Stewart ◽  
M. Kocak ◽  
A. J. Gajjar ◽  
...  

2007 ◽  
Vol 13 (22) ◽  
pp. 6712-6718 ◽  
Author(s):  
Alberto Broniscer ◽  
Sridharan Gururangan ◽  
Tobey J. MacDonald ◽  
Stewart Goldman ◽  
Roger J. Packer ◽  
...  

2017 ◽  
Vol 19 (suppl_4) ◽  
pp. iv34-iv35 ◽  
Author(s):  
Jason Fangusaro ◽  
Arzu Onar-Thomas ◽  
Tina Y Poussaint ◽  
Shengjie Wu ◽  
Azra H Ligon ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document